The role of surgery in the treatment of distant metastases of skin melanomar
https://doi.org/10.18027/2224-5057-2016-3-25-31
Abstract
The choice of tactics in the treatment of one of the most common types of cancer skin- melanomy- is currently an urgent task facing the cancer community. High activity of local growth and regional metastasis of melanoma, its capacity for dissemination and multiple distant metastases make this task extremely important factor, largely determining the course and outcome of disease. Metastatic melanoma skin requires complex treatment, one of whose components is the surgical method. This article analyzes the use of surgical treatment of distant metastases of melanoma, depending on the location, quantity and rate of growth, the nature and effectiveness of previous treatment, the patient’s general condition. The authors have shown the prospects of application of surgical treatment in the radical treatment of patients with distant metastases of melanoma, the effectiveness of this method in the palliative treatment of metastatic melanoma and important role in the treatment of distant metastases of melanoma in combination with other treatments.
About the Authors
K. S. TITOV
Moscow Clinical Research Centr; Department of Oncology and Radiation Therapy Russian National
Russian Federation
Russian Federation
MD, RhD, DSc, head of the Оnсоsurgery Department tumors of skin and soft fabrics; assistant professor
O. Y. MIKHEEVA
Moscow Clinical Research Centr
Russian Federation
MD, RhD, a researcher of Оnсоsurgery Department tumors of skin and soft fabrics
Russian Federation
MD, RhD, a researcher of Оnсоsurgery Department tumors of skin and soft fabrics
A. M. KAZAKOV
Russian National Medical University
Russian Federation
student
Russian Federation
student
A. V. EGOROVA
Russian National Medical University
Russian Federation
Russian Federation
MD, RhD, assistant professor of the Department of Oncology and Radiation Therapy
References
1. Torre L.A. Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemak A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar; 65(2):87–108.
2. Balch C.M., Gershenwald J.E., Soong S.J., et al. Final version of 2009AJCC melanoma staging and classification. J Clin Oncol. 2009; 27(36):6199–6206.
3. Thompson J.F., Morton D.L., Balch C.M., et al. Surgical excision of distant melanoma metastases. In: Balch CMea., editor. Cutaneous Melanoma. St. Louis: Quality Medical Publishing; 2009.
4. Михайлова И. Н., Шубина И. Ж., Титов К. С., Мамедова Л. Т. Химиоиммунотерапия онкологических больных // Вопросы онкологии. – 2015. –№ 5. – С. 716–718. Mikhaylova I. N., Choubina I. Zh., Titov K. S., Mamedova of L. T. Himioimmunoterapiya of oncological patients//Questions of oncology. – 2015. –№ 5. – Page 716–718.
5. Демидов Л. В., Булавина И. С., Гладков О. А., Зинькевич М. В., Марочко А. Ю., Новик А. В. и соавт. Практические рекомендации по лекарственному лечению меланомы кожи // Злокачественные опухоли. – 2015. – № 4, спецвыпуск. – С. 162–170. Demidov L. V., Bulavina I. S., Gladkov O. A., Zinkevich M. V., Marochko A. Yu., Novick A. V. et al. Practical recommendations about medicinal treatment of a melanoma of skin//Malignant tumors. – 2015. – No. 4, special issue. – Page 162–170.
6. Batus M., Waheed S., Ruby C., Petersen L., Bines S.D., Kaufman H.L.: Optimal management of metastatic melanoma: current strategies and future directions. Am J Clin Dermatol 14: 179–194, 2013.
7. Karakousis C. Et al. Local recurrence in malignant melanoma: Long-term results of the multi institutional randomized surgical trial // Ann. Surg. Oncol. – 1996. – Vol.3. – P. 440.
8. Anna M. Leung, MD, Surgical Oncology Fellow, Danielle M. Hari, MD. Surgery for Distant Melanoma Metastasis. Cancer J. 2012 Mar; 18(2): 176–184.
9. Clawson G.A., Kimchi E., Patrick S.D., Xin P., Harouaka R., Zheng S., Berg A., Schell T., Staveley-O’Carroll K.F., Neves R.I., Mosca P.J., Thiboutot D. Circulating tumor cells in melanoma patients. PLoS One. 2012; 7(7): e41052.
10. Wasif N., Bagaria S.P., Ray P., Morton D.L. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011 Aug 1;104(2):111–5.
11. Younes R., Abrao F.C., Gross J. Pulmonary metastasectomy for malignant melanoma: prognostic factors for long-term survival. Melanoma Res. 2013 Aug; 23 (4):307–11.
12. Neuman H.B., Patel ., Hanlon C., Wolchok J.D., Houghton A.N., Coit D.G. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol. 2007 Oct; 14 (10):2847–53.
13. Doussot A., Nardin C., Takaki H., Litchman T.D., D’Angelica M.I., Jarnagin W.R., Postow M.A., Erinjeri J.P., Kingham T.P. Liver resection and ablation for metastatic melanoma: A single center experience. J Surg Oncol. 2015 Jun;111(8): р. 962–8.
14. Nabil Wasif, MD, Sanjay P Bagaria, MD, Partha Ray, MD, and Donald L Morton, MD, FACS. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. Surg Oncol. Author manuscript; available in PMC2012 Aug 1. 15. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001; 136:950–955.
15. Bo ena Cybulska-Stopa, Marta Skoczek, Marek Ziobro, Tomasz witaj, S awomir Falkowski, Tadeusz Morysi ski, Marcin Hetna , Ida Cedrych, and Piotr Rutkowski. Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV. Contemp Oncol (Pozn). 2013; 16(6): 532–545.
16. Петроченко Н. С. «Изолированная перфузия конечностей с гипертермией у больных с местно-диссеминированной меланомой кожи и саркомами мягких тканей». Москва. – дисс. к. м.н., 2015. Petrochenko N. S. «The isolated perfusion of extremities with a hyperthermia at patients with a local disseminirovannoy a melanoma of skin and sarcomas of soft fabrics». Moscow. – yew. Candidates of Medical Science., 2015.
17. Jason J. Lukecorresponding authora and F. Stephen Hodi. Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAFMutant Malignant Melanoma. Oncologist. 2013 Jun; 18(6): р. 717–725.
18. Eggermont A.M., Chiarion-Sileni V., Grob J.J., Dummer R., Wolchok J.D., Schmidt H., Hamid O. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015 May;16 (5): р. 522–30.
19. Shachar Laks, Kevin A Brueske, and Eddy C Hsueh. Neoadjuvant treatment of melanoma: case reports and review. Exp Hematol Oncol. 2013; 2:30.
20. Baker J.J., Stitzenberg K.B., Collichio F.A., Meyers M.O., Ollila D.W. Systematic review: surgery for patients with metastatic melanoma during active treatment with ipilimumab. Am Surg. 2014 Aug; 80(8):805–10.
21. Fadaki N., Cardona-Huerta S., Martineau L., Thummala S., Cheng S.T., Bunker S.R. et al. Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib. BMJ Case Rep. 2012; р.22.
22. Koers K., Francken A.B., Haanen J.B., Woerdeman L.A., von der Hage J.A. Vemurafenib as eoadjuvant treatment for unresectable regional metastatic melanoma. J Clin Oncol. 2013;31(16): e251–3.
23. Shenoy S., Cassim R. Metastatic melanoma to the gastrointestinal tract: role of surgery as palliative treatment. W V Med J. 2013; 109(January–February (1)): р. 30–33.
24. Szynglarewicz B., Ekiert M., Forgacz J., Halon A., Skalik R., Matkowski R. The role of surgery in the treatment of colorectal metastases from primary skin melanoma. Colorectal Dis. 2012;14(June (6)): р. 305–e311.
25. Angelica Conversano, Simona Macina, Rocco Indellicato, Domenico Lacavalla, and Dario D’Abbicco. Gastrointestinal bleeding as presentation of small bowel metastases of malignant melanoma: Is surgery a good choice? Int J Surg Case Rep. 2014; 5(10): р. 774–778.
Review
For citations:
TITOV K.S., MIKHEEVA O.Y., KAZAKOV A.M., EGOROVA A.V. The role of surgery in the treatment of distant metastases of skin melanomar. Malignant tumours. 2016;(3):25-31. (In Russ.) https://doi.org/10.18027/2224-5057-2016-3-25-31
Views:
876
Email this article 